Metabolic Activation of N-Hydroxylated Metabolites of Carcinogenic and Mutagenic Arylamines and Arylamides by Esterification

References

• Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential address. Cancer Res. 1978; 38: 1479–1496
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Beland F. A. Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides. Polycyclic Hydrocarbons and Carcinogenesis, R. Harvey. American Chemical Soc, Washington, DC 1985; 341–370
   Google Scholar
• Kato R. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit. Rev. Toxicol., 16: 307–348
   Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Matsuda N., Ishii K., Kato R. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Mol. Pharmacol. 1983; 24: 146–155
   PubMed Web of Science ®Google Scholar
• King C. M., Philips B. Enzyme-catalyzed reactions of the carcinogen yV-hydroxy-2-fluorenylacetamide with nucleic acid. Science 1968; 159: 1351–1353
   PubMed Web of Science ®Google Scholar
• DeBaun J. R., Miller E. C., Miller J. A. N-Hydroxy-2-acetylaminofluorene sulfotransferase: Its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res. 1970; 30: 577–595
   PubMed Web of Science ®Google Scholar
• DeBaun J. R., Smith J. Y. R., Miller E. C., Miller J. A. Reactivity in vivo of the carcinogen N-hydroxy-2-acetylaminofluorene: Increase by sulfate ion. Science 1970; 167: 184–186
   PubMed Web of Science ®Google Scholar
• Weisburger J. H., Yamamoto R. S., Williams G. M., Grantham P. H., Matsushima T., Weisburger E. K. On the sulfate ester of N-hydroxy-Af-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res. 1972; 32: 491–500
   PubMed Web of Science ®Google Scholar
• Lai C. C., Miller J. A., Miller E. C., Liem A. N-Sulfoxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of yV-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ Fl (B6C3F1) mice. Carcinogenesis 1985; 6: 1037–1045
   PubMed Web of Science ®Google Scholar
• Kadlubar F F., Miller J. A., Miller E. C. Hepatic metabolism of AMiydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy ary-lamines to reactive sulfuric acid esters. Cancer Res. 1976; 36: 2350–2359
   PubMed Web of Science ®Google Scholar
• Delclos K. B., Miller E. C., Miller J. A., Liem A. Sulfuric acid esters as major ultimate electrophilic and hepatocarcinogenic metabolites of 4-aminoazobenzene and its N-methyl derivatives in infant male C57BL/6J x C3H/HeJ F, (B6C3F,) mice. Carcinogenesis 1986; 7: 277–287
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and aminoacid pyrolysates. Jpn. J. Cancer Res. (Gann) 1987; 78: 297–311
   PubMedGoogle Scholar
• Yamazoe Y, Manabe S., Murayama N., Kato R. Regulation of hepatic sulfotransferase catalyzing the activation of N-hydroxyarylamide and AMiydroxyarylamine by growth hormone. Mol. Pharmacol. 1987; 32: 536–542
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Abu-Zeid M., Dawei G., Staiano N., Kato R. Enzymatic acetylation and sulfation of AMrydroxyarylamines in bacteria and rat livers. Carcinogenesis 1989; 10: 1675–1679
   PubMed Web of Science ®Google Scholar
• Abu-Zeid M., Yamazoe Y., Kato R. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines (amide) in liver cytosols from human and experimental animals. Carcinogenesis 1992; 13: 1307–1314
   PubMed Web of Science ®Google Scholar
• Gong D., Ozawa S., Yamazoe Y, Kato R. Purification of hepatic AMiydroxyarylamine sulfotransferases and their regulation by growth hormone and thyroid hormone in rats. J.Biochem. 1991; 110: 226, 231
   PubMed Web of Science ®Google Scholar
• Nagata K., Ozawa S., Miyata M., Shimada M., Gong D. -W., Yamazoe Y., Kato R. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 1993; 268: 24720–24725
   PubMed Web of Science ®Google Scholar
• Ozawa S., Nagata K., Gong D. W., Yamazoe Y., Kato R. Nucleotide sequence of a full length cDNA (PST-1) for aryl sulfotransferase from rat liver,. Nucleic. Acids Res. 1990; 18: 4001
   PubMed Web of Science ®Google Scholar
• Yerokun T., Etheredge J. L., Norton T. R., Carter H. A., Chung K. H., Birckbichler P. J., Ringer D. P. Characterization of a complementary DNA for rat liver aryl sulfotransferase-IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Cancer Res. 1992; 52: 4779–4786
   PubMed Web of Science ®Google Scholar
• Sekura R. D., Jakoby W. B. Aryl sulfotransferase IV from rat liver. Arch. Biochem. Biophys. 1981; 211: 352–359
   PubMed Web of Science ®Google Scholar
• Bartsch H., Dworkin M., Miller J. A., Miller E. C. electrophilic N-acetoxyaminoarenes derived from carcinogenic iV-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. Biochem. Biophys. Acta 1972; 286: 272–298
   PubMed Web of Science ®Google Scholar
• Weber W. W., Hein D. W. N-acetylation pharmacogenetics. Pharm. Rev. 1985; 37: 25–79
   PubMed Web of Science ®Google Scholar
• Allaben W. T., King C. M. The purification of rat liver arylhy-droxamic acid N,0-acyltransferase. J. Biol. Chem. 1984; 259: 12128–12134
   PubMedGoogle Scholar
• King C. M., Glowinski I. B. Acetylation, deacetylation and acyl-transfer. Environ. Health Perspec 1983; 49: 43–50
   PubMed Web of Science ®Google Scholar
• Glowinski I. B., Weber W. W. Evidence that arylhydroxamic acid N,O-acytransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver. J. Biol. Chem. 1980; 255: 7883–7890
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Shimada M., Kamataki T., Kato R. Covalent binding of N-hydroxy-Trp-P-2 to DNA by cytosolic proline-dependent system. Biochem. Biophys. Res. Commun. 1982; 107: 165–172
   PubMed Web of Science ®Google Scholar
• Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. DNA binding of N-hydroxy-Trp-P-2 and N-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mammalian liver cytosol. Carcinogenesis 1985; 6: 305–307
   PubMed Web of Science ®Google Scholar
• Flammang T. J., Westra J. G., Kadlubar F. F., Beland F. A. DNA adducts formed from the probable proximate carcinogen, N-hydroxy-3,2′-dimethyl-4-aminobiphenyl, by acid catalysis or 5-acetyl coenzyme A-dependent enzymatic esterification. Carcinogenesis 1985; 6: 251–258
   PubMed Web of Science ®Google Scholar
• Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. Acetyl coenzyme A-dependent activation of N-hydroxy derivative of carcinogenic arylamines: Mechanism of activation, species difference, tissue distribution and acetyl donor specificity. Cancer Res. 1986; 46: 4362–4367
   PubMed Web of Science ®Google Scholar
• Flammang T. J., Kadlubar F. F. Acetyl coenzyme A-dependent metabolic activation and A'-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several carcinogenic AMiydroxyarylamines in relation to tissue and species differences, other acetyldonors, and arylhydroxamic acid-dependent acyltransferases. Carcinogenesis 1986; 7: 919–926
   PubMed Web of Science ®Google Scholar
• Saito K., Shinohara A., Kamataki T., Kato R. N-Hydroxyaryl-amine O-acetyltransferase in hamster liver: Identity with arylhydroxamic acid NO-acetyltransferase and arylamine A'-acetyltransferase. J. Biochem. 1986; 99: 1689–1697
   PubMed Web of Science ®Google Scholar
• Hanna P, Banks P B., Marhevka V. C. Suicide inactivation of hamster hepatic arylhydroxamic acid A'.O-acyltransferase A selective probe of A'-acetyltransferase multiplicity. Mol. Pharmacol. 1982; 21: 159–165
   PubMed Web of Science ®Google Scholar
• Hein D. W., Kirlin W. G., Ferguson R. J., Weber W. W. Inheritance of liver A'-acetyltransferase activity in the rapid and slow acety-lator inbred hamster. J. Pharmacol. Exp. Ther. 1985; 233: 584–587
   PubMed Web of Science ®Google Scholar
• Kawakubo Y., Manabe S., Yamazoe Y., Nishikawa T., Kato R. Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and AMiydroxyarylamine. Biochem. Pharmacol. 1988; 37: 265–270
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Further metabolic activations of mutagenic and carcinogenic Af-hydroxy arylamine by conjugating enzymes. Xe-nobiotic Metabolism and Disposition, R. Kato, R. W. Estabrook, M. N. Cayen. Taylor & Francis, London 1989; 383–391
   Google Scholar
• Ozawa S., Abu-Zeid M., Kawakubo Y., Toyama S., Yamazoe Y., Kato R. Monomorphic and polymorphic isozymes of arylamine A'-acetyltransferase in hamster liver: Purification of the isozymes and genetic basis of A'-acetylation polymorphism. Carcinogenesis 1990; 11: 2137–2144
   PubMed Web of Science ®Google Scholar
• Hein D. W., Flammang T. J., Kirlin W. G., Trinidad A., Ogolla F. Acetylator genotype-dependent metabolic activation of carcinogenic AMiydroxyarylamines by 5-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: Relationship to arylamine A'-acetyltransferase. Carcinogenesis 1987; 8: 1767–1774
   PubMed Web of Science ®Google Scholar
• Trinidad A., Hein D. W., Rustan T. D., Ferguson R. J., Miller L. S., Bucher K. D., Kirlin W. G., Ogolla F., Andrews A. F. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: Identity with polymorphic AMiydroxyarylamine-O-acetyltransferase. Cancer Res. 1990; 50: 7942–7949
   PubMed Web of Science ®Google Scholar
• Abu-Zeid M., Nagata K., Miyata M., Ozawa S., Fukuhara M., Yamazoe Y., Kato R. An arylamine acetyltransferase (AT-I) from Syrian golden hamster liver: Cloning, complete nucleotide sequence, and expression in mammalian cells. Mol. Carcinogenesis 1991; 4: 81–88
   PubMed Web of Science ®Google Scholar
• Levy G. N., Martell K. J., DeLeon J. H., Weber W. W. Metabolic molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice. Pharmacogenetics 1992; 2: 197–206
   PubMedGoogle Scholar
• Meyer U. A., Zanger U. M., Grant D., Blum M. Genetic polymorphisms of drug metabolism. Adv. Drug Res. Academic Press, New York 1990; 198–241
   Google Scholar
• Blum M., Demierre A., Grant D. M., Heim M., Meyer U. A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA 1991; 88: 5237–5241
   PubMed Web of Science ®Google Scholar
• Tada M., Tada M. Seryl-fRNA synthetase and activation of the carcinogen 4-nitroquinoline 1-oxide. Nature 1975; 255: 510–512
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Tada M., Kamataki T., Kato R. Enhancement of binding of N-hydroxy-Trp-P-2 to DNA by seryl-/RNA synthetase. Bio-chem. Biphys. Res. Commun. 1981; 102: 432–439
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Shimada M., Shinohara A., Saito K., Kamataki T., Kato R. Catalysis of the covalent binding of 3-hydroxyamino-1-methyl-5//-pyrido[4,3-fo]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol. Cancer Res. 1985; 45: 2495–2500
   PubMed Web of Science ®Google Scholar
• Beranek D. T., White G. L., Heflich R. H., Beland F. A. Ami-nofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. Proc. Natl. Acad. Sci. USA 1982; 79: 5175–5178
   PubMed Web of Science ®Google Scholar
• Saito K., Yamazoe Y., Kamataki T., Kato R. Mechanism of activation of proximate mutagens in Ames' tester strains: The acetyl CoA-dependent enzyme in Salmonella typhimurium TA98 deficient in TA98/1,8-DNP6 catalyzes DNA binding as the cause of mutagenicity. Biochem. Biochem. Biphys. Res. Commun. 1983; 116: 141–147
   PubMed Web of Science ®Google Scholar
• Saito K., Shinohara A., Kamataki T., Kato R. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys. 1985; 239: 286–295
   PubMed Web of Science ®Google Scholar
• McCoy E. C., Anders M., Rosenkranz H. S. The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP6 to the mutagenic action of nitroarenes. Mutat. Res. 1983; 121: 17–23
   PubMed Web of Science ®Google Scholar
• Ando M., Shindo Y., Fujita M., Ozawa S., Yamazoe Y., Kato R. A new Salmonella tester strain expressing a mammalian acetyltrans-ferase shows high sensitivity for arylamines. Mutat. Res. 1993; 292: 155–163
   PubMed Web of Science ®Google Scholar
• Nagata K., Ozawa S., Miyata M., Shimada M., Yamazoe Y., Kato R. Primary structure and molecular basis of polymorphic appearance of an acetyltransferase, AT-II, in hamster. Pharmacogenetics 1994; in press
   Google Scholar